image
Xilio Therapeutics, Inc. XLO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.6885
4.22 %
$ 35.7 M
Market Cap
-1.06
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
12.05%
EBIT Estimate
20.37%
Net Income Estimate
--16.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Xilio Therapeutics, Inc.
image
XLO has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart XLO

image
$30.0m$30.0m$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart XLO

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart XLO

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)20232023202420242025202520262026202720272028202820292029